Inventor
JI YU-HUA
US62 patents
⚠️ This page may combine multiple inventors who share the name “JI YU-HUA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
THERAVANCE INC
43 patentsUS7288657B2Oct 30, 2007
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC71 citations99
US7265133B2Sep 4, 2007
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC65 citations98
US8017783B2Sep 13, 2011
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC17 citations96
US7910608B2Mar 22, 2011
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC32 citations96
US7585879B2Sep 8, 2009
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC35 citations96
US7560469B2Jul 14, 2009
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC37 citations96
US7550595B2Jun 23, 2009
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC37 citations96
US7521041B2Apr 21, 2009
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC27 citations96
US7491736B2Feb 17, 2009
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC29 citations96
US7456199B2Nov 25, 2008
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC49 citations96
US7262205B2Aug 28, 2007
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC50 citations96
US7816532B2Oct 19, 2010
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC16 citations93
US7687519B2Mar 30, 2010
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC25 citations93
US7683173B2Mar 23, 2010
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC23 citations93
US7659403B2Feb 9, 2010
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC25 citations93
US7642355B2Jan 5, 2010
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC32 citations93
US7632847B2Dec 15, 2009
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC24 citations93
US7629336B2Dec 8, 2009
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC29 citations93
US7569588B2Aug 4, 2009
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC34 citations93
US7524962B2Apr 28, 2009
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC37 citations93
US7501442B2Mar 10, 2009
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC40 citations93
US7479562B2Jan 20, 2009
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC39 citations93
US7851631B2Dec 14, 2010
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC15 citations92
US7728144B2Jun 1, 2010
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC20 citations92
US7569586B2Aug 4, 2009
Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity
THERAVANCE INC23 citations92
US7183292B2Feb 27, 2007
Substituted pyrrolidine and related compounds
THERAVANCE INC14 citations92
US7524880B2Apr 28, 2009
Crystalline form of a substituted pyrrolidine compound
THERAVANCE INC23 citations89
US6420560B1Jul 16, 2002
H1—histamine receptor antagonists
THERAVANCE INC23 citations88
US7858795B2Dec 28, 2010
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC14 citations84
US7858797B2Dec 28, 2010
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC13 citations84
US7851632B2Dec 14, 2010
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC14 citations84
US7285564B2Oct 23, 2007
Substituted 4-amino-1-(pyridylmethyl)piperidine and related compounds
THERAVANCE INC10 citations84
US6897305B2May 24, 2005
Calcium channel drugs and uses
THERAVANCE INC16 citations83
US7368463B2May 6, 2008
Substituted 4-amino-1-benzylpiperidine compounds
THERAVANCE INC7 citations74
US7351717B2Apr 1, 2008
Substituted pyrrolidine and related compounds
THERAVANCE INC4 citations74
US7351718B2Apr 1, 2008
Substituted pyrrolidine and related compounds
THERAVANCE INC4 citations74
US7250414B2Jul 31, 2007
Diphenylmethyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC7 citations74
US7071224B2Jul 4, 2006
Diphenylmethyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC9 citations74
US6750241B2Jun 15, 2004
Protein kinase inhibitors
THERAVANCE INC5 citations74
US6576791B1Jun 10, 2003
Local anesthetic compounds and uses
THERAVANCE INC10 citations72
US6815555B2Nov 9, 2004
Substituted phenol compounds useful for anesthesia and sedation
THERAVANCE INC5 citations61
US6462034B1Oct 8, 2002
Local anesthetic compounds and uses
THERAVANCE INC3 citations61
US7858792B2Dec 28, 2010
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC0 citations52
HOFFMANN LA ROCHE
4 patentsUS5856503AJan 5, 1999
Aminoalkyl-substituted benzo-heterocyclic compounds
HOFFMANN LA ROCHE81 citations96
US6140353AOct 31, 2000
N-(4-carb-amimidophenyl)glycineamide derivatives
HOFFMANN LA ROCHE35 citations92
US5824698AOct 20, 1998
Antibacterial dibenzimidazole derivatives
HOFFMANN LA ROCHE54 citations91
US6441177B1Aug 27, 2002
Tertiary amines
HOFFMANN LA ROCHE5 citations62
ADVANCED MEDICINE INC
2 patentsMAMMEN MATHAI
1 patentShowing the top 50 of 62 patents by PatentIndex Score.